In conclusion, our data show a partially protective effect of Nlrp2 inhibition in the cystinotic mouse model and provide additional rationale for testing anti-inflammatory strategies in addition to cysteamine to delay progression of kidney disease in patients with cystinosis. Here, NLRP2 is linked to cystinosis.